In addition, the expression level of filaggrin was reduced by C3A and GGRT treatment, and the expression levels of dermatitis-related proteins, including KLK7, PAR-2, TSLP, and IL-4, were markedly recovered. The gene discussed is FLG; the disease is skin disorder.